Key message 1
Low level viremia ≠ treatment success
Patients on treatment with low-level viremia below the 1000 copies/mL threshold for virological failure set by WHO are currently labelled as successfully treated. However, these patients are at increased risk of poor treatment outcomes when compared to patients with successful virological suppression of less than 50 copies per mL.
About ITREMA
The ITREMA project is funded bij ZonMw and supported by the African HIV Care & Cure (AHC²) Foundation and the Aidsfonds. ITREMA is a collaboration between investigators from the University Medical Center Utrecht (UMCU), Utrecht University, Radboud University Medical Center Nijmegen, the University of the Witwatersrand (Johannesburg, South Africa) and Ndlovu Care Group (NCG, Limpopo, South Africa).
Get in contact with us
ITREMA
Heidelberglaan 100
3584 CX Utrecht, The Netherlands
Location
University Medical Centre Utrecht, Department of Medical Microbiology
+31 88 75 565 26
f.bikhezar@umcutrecht.nl
